75
Participants
Start Date
October 31, 2006
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
aflibercept
Given intravenously
University Health Network-Princess Margaret Hospital, Toronto
National Cancer Institute (NCI)
NIH